期刊文献+

英夫利西在儿童克罗恩病中的应用 被引量:1

Application of Infliximab in Children with Crohn′s Disease
原文传递
导出
摘要 英夫利西作为一种针对肿瘤坏死因子的单克隆抗体,在儿童克罗恩病(CD)的治疗中已开始应用。许多大的随机对照研究已经显示其对儿童CD的诱导缓解和维持治疗具有良好的疗效,尤其是生长发育的恢复及降低肠切除术的概率,提高患儿的生活质量。英夫利西的治疗方案包括诱导缓解和维持治疗,前者在第0、2、6周以5 mg.kg-1的剂量静脉滴注,后者在缓解后每8周以相同剂量维持治疗。在治疗过程中要注意调整剂量和用药间隔,以避免失效。严重感染、输液反应、药物性红斑狼疮等不良反应也是重点关注的问题,目前英夫利西是否有致癌的可能性并不清楚,需要长期的随访观察。
作者 朱朝敏 彭哲
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2011年第7期477-479,共3页 Journal of Applied Clinical Pediatrics
  • 相关文献

参考文献24

  • 1江米足.青少年儿童炎症性肠病诊断指南(波尔图标准)[J].实用儿科临床杂志,2006,21(7):443-445. 被引量:22
  • 2Reimund JM, Wittersheim C, Dumont S ,et al. Mueosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease[ J]. J Clin Immunol, 1996,16 ( 3 ) : 144 - 150.
  • 3Onrust SV,Lamb HM. Infliximab:A review of its use in Crohn's disease and rheumatoid arthritis[ J]. BioDrugs, 1998,10 (5) :397-422.
  • 4Keating GM, Perry CM. Infliximab: An updated review of its use in Crohn's disease and rheumatoid arthritis [ J ]. BioDrugs, 2002, 16 ( 2 ) : 111 -148.
  • 5Markham A, Lamb HM. Infliximab:A review of its use in the management of rheumatoid arthritis [ J ]. Drugs, 2000,59 ( 6 ) : 1341 - 1359.
  • 6Hyams JS, Markowitz J, Wyllie R. The use of infliximab in the treatment of Crohn's disease in children and adolescents[ J]. J Pediatr ,2000 ,137 (2) :192 -196.
  • 7Hyams JS, Crandall W, Kugathasan S, et al. Induction and maintenance infliximab therapy for the treatment of moderate - to - severe Crohn's disease in children[J]. Gastroenterology,2007,132 (3) :863 - 873.
  • 8Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease:The ACCENT I randomised trial[J]. Lancet,2002, 359(9317) : 1541 - 1549.
  • 9Baldassano R, Braegger CP, Escher JC, et al Infliximab ( REMICADE ) therapy in the treatment of pediatric Crohn's disease [ J ]. Am J Gastroenterol,2003,98 (4) :833 - 838.
  • 10Lamireau T,Cezard JP,Dabadie A ,et al. French - Speaking Group for Pediatric Gastroenterology Nutrition. Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease [J]. lnflamm Bowel Dis,2004,10 (6) : 745 - 750.

二级参考文献12

  • 1Targan SR, Hanauer SB, van Deventer SJ,et al. A shortterm study of chimeric monoelonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N EnglJ Med, 1997,337:1029-1035.
  • 2Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT Ⅰ randomised trial. Lancet, 2002,359: 1541-1549.
  • 3Present DH, Rutgeerts P, Targan S,et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med, 1999,340:1398-1405.
  • 4Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med, 2004,350:876-885.
  • 5Rutgeerts P, Van Assehe G, Vermeire S. Review article: Infliximab therapy for inflammatory bowel disease-seven years on. Aliment Pharmaeol Ther, 2006,23: 451-463.
  • 6Lichtenstein GR, Abreu MT, Cohen R, et al. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology, 2006, 130:940-987.
  • 7Clark M, Colombel JF, Feagan BC,et al. American gastro enterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology, 2007, 133: 312-339.
  • 8Travis SP, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease : current management. Gut, 2006,55 (Suppl 1 ) :i16-i35.
  • 9Rampton DS. Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNP therapy. Gut, 2005, 54:1360-1362.
  • 10Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med, 2003,348:601-608.

共引文献27

同被引文献15

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部